IndraLab

Statements

USP18 activates EGFR. 9 / 10
| 9
reach
"In addition, the results indicated that USP18 may promote the epidermal growth factor (EGF)-mediated EGF receptor (EGFR)/AKT/S-phase kinase associated protein2 (Skp2) pathway by upregulating EGFR and Skp2 in a AKT and forkhead boxO3 dependent manner in breast cancer."
29749454
reach
"USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT and Skp2 pathway."
29749454
reach
"Inhibition of USP18 reduces the levels of EGFR and other oncogenic proteins and inhibits the tumorigenic activity of cancer cells."
24616583
reach
"However, USP18 has independent direct effects on tumor growth and survival and enhances EGFR signaling by decreasing miR-7 expression, which targets EGFR [54]."
29852322
reach
"However, USP18 has independent direct effects on tumor growth and survival and enhances EGFR signaling by decreasing miR-7 expression, which targets EGFR XREF_BIBR."
29852322
reach
"For instance, Tan et al. found that USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT and Skp2 pathway [XREF_BIBR]."
33051403
reach
"Moreover, USP18 competitively inhibits IFN-alpha and beta-induced JAK and STAT activation [XREF_BIBR] and upregulates epidermal growth factor receptor (EGFR) expression [XREF_BIBR]."
26046984
reach
"In addition, the results indicated that USP18 may promote the epidermal growth factor (EGF)-mediated EGF receptor (EGFR)/AKT/S-phase kinase associated protein2 (Skp2) pathway by upregulating EGFR and Skp2 in a AKT and forkhead boxO3 dependent manner in breast cancer."
29749454
reach
"Tan et al. have demonstrated that USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT and Skp2 pathway."
33051403